Third-line targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium

JC Wells, I Stukalin, C Norton, S Srinivas, JL Lee… - European urology, 2017 - Elsevier
Background The use of third-line targeted therapy (TTT) in metastatic renal cell carcinoma
(mRCC) is not well characterized and varies due to the lack of robust data to guide treatment …
被引用次数：87 相关文章

Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

JC Wells, I Stukalin, C Norton, S Srinivas, JL Lee… - European Urology, 2017 - pure.au.dk
BACKGROUND: The use of third-line targeted therapy (TTT) in metastatic renal cell
carcinoma (mRCC) is not well characterized and varies due to the lack of robust data to …

Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

JC Wells, I Stukalin, C Norton, S Srinivas… - European …, 2017 - pubmed.ncbi.nlm.nih.gov
Background The use of third-line targeted therapy (TTT) in metastatic renal cell carcinoma
(mRCC) is not well characterized and varies due to the lack of robust data to guide treatment …

Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

JC Wells, I Stukalin, C Norton, S Srinivas, JL Lee… - European Urology, 2017 - infona.pl
The use of third-line targeted therapy (TTT) in metastatic renal cell carcinoma (mRCC) is not
well characterized and varies due to the lack of robust data to guide treatment decisions …

Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

JC Wells, I Stukalin, C Norton, S Srinivas, JL Lee… - European …, 2016 - europepmc.org
Background The use of third-line targeted therapy (TTT) in metastatic renal cell carcinoma
(mRCC) is not well characterized and varies due to the lack of robust data to guide treatment …
[PDF] researchgate.net

[PDF][PDF] Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

JC Wells, I Stukalin, C Norton, S Srinivas, JL Lee… - 2016 - researchgate.net
Background: The use of third-line targeted therapy (TTT) in metastatic renal cell carcinoma
(mRCC) is not well characterized and varies due to the lack of robust data to guide treatment …

[引用][C] Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

JC Wells, I Stukalin, C Norton, S Srinivas, JL Lee… - European Urology, 2017 - cir.nii.ac.jp
Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International
Metastatic Renal Cell Carcinoma Database Consortium | CiNii Research CiNii 国立情報学 …